Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients

Augmented Renal Clearance in the ICU

(2013) Andrew A. Udy et al.   CRITICAL CARE MEDICINE

Can changes in renal function predict variations in β-lactam concentrations in septic patients?

(2013) Giuseppe Stefano Casu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Dose modulation: A new concept of antibiotic therapy in the critically ill patient?

(2013) Joao Goncalves-Pereira et al.   JOURNAL OF CRITICAL CARE

Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections

(2013) Lutz Binder et al.   THERAPEUTIC DRUG MONITORING

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

(2012) J. M. Dulhunty et al.   CLINICAL INFECTIOUS DISEASES

β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

(2012) Yoshiro Hayashi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Continuous Infusion of Piperacillin/Tazobactam in Septic Critically Ill Patients—A Multicenter Propensity Matched Analysis

(2012) João Gonçalves-Pereira et al.   PLoS One

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

(2012) Fekade Sime et al.   Annals of Intensive Care

Empirical models for dosage optimization of four β-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin

(2009) Isabelle K. Delattre et al.   CLINICAL BIOCHEMISTRY

The Pathophysiology of Septic Shock

(2009) O. Okorie Nduka et al.   CRITICAL CARE CLINICS

A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS